Hepatic artery embolization: Factors predisposing to postembolization pain and nausea

被引:28
作者
Patel, NH
Hahn, D
Rapp, S
Bergan, K
Coldwell, DM
机构
[1] Indiana Univ, Sch Med, Dept Radiol, Indianapolis, IN 46202 USA
[2] Indiana Univ, Sch Med, Dept Med, Div Biostat, Indianapolis, IN USA
[3] Univ Washington, Sch Med, Dept Radiol, Seattle, WA 98195 USA
[4] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA
[5] Univ Maryland Med Syst, Dept Radiol, Baltimore, MD USA
关键词
embolization; hepatic arteries; therapeutic blockade; liver neoplasms; therapy;
D O I
10.1016/S1051-0443(07)61377-3
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PURPOSE: Analysis of preprocedural factors that may be helpful in predicting the severity of pain and nausea after hepatic arterial embolization (HAE) for liver neoplasms. MATERIALS AND METHODS: During a a-year period, 62 patients (33 men, 29 women) underwent 130 palliative lobar HAEs for unresectable liver neoplasms, The hepatic lobe was embolized with 150-250-mu m polyvinyl alcohol particulates with or without lipiodol and/or chemotherapeutic agents, Postembolization pain was rated at rest and during movement with use of an Ii-point verbal pain scale, and postembolization nausea was assessed with use of a four-point verbal scale, each at two separate time periods. Daily morphine use was also recorded. Primary analysis was made using the first embolization procedure. One-way analysis of variance and Spearman correlation coefficients were used to identify associated predictors. Plots of the outcomes versus the pre-embolization liver function tests and sensitivities and specificities were used to identify the strength of the associations for prediction purposes. A secondary analysis was performed in patients who underwent multiple embolizations. RESULTS: No strong categorical predictors were found from the ANOVA on the severity of postembolization pain or nausea. There were significant (P < .05) associations between the pre-embolization liver function tests and the pain outcomes only. However, while these laboratory values demonstrate strong associations with resultant pain, they are not strong predictors of pain and morphine requirements for any individual patient. The morphine requirements were highly associated (P < .0001) with the pain scores at rest and with movement. The authors did not find significant differences on any of the pain outcomes or morphine requirements between the first and second embolizations. CONCLUSION: Laboratory values and patient age are not predictors for the severity of postembolization pain and nausea. Postembolization pain is a significant complication and poses a continuing challenge to the physician with regards to patient management.
引用
收藏
页码:453 / 460
页数:8
相关论文
共 24 条
[1]  
Akriviadis EA, 1998, BRIT J SURG, V85, P1319
[2]  
Bavisotto LM, 1999, CLIN CANCER RES, V5, P95
[3]   HEPATIC-ARTERY CHEMOEMBOLIZATION OR EMBOLIZATION FOR PRIMARY AND METASTATIC LIVER-TUMORS - POSTTREATMENT MANAGEMENT AND COMPLICATIONS [J].
BERGER, DH ;
CARRASCO, CH ;
HOHN, DC ;
CURLEY, SA .
JOURNAL OF SURGICAL ONCOLOGY, 1995, 60 (02) :116-121
[4]   Arterial hepatic embolization of unresectable hepatocellular carcinoma using a cyanoacrylate/lipiodol mixture [J].
Berghammer, P ;
Pfeffel, F ;
Winkelbauer, F ;
Wiltschke, C ;
Schenk, T ;
Lammer, J ;
Muller, C ;
Zielinski, C .
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 1998, 21 (03) :214-218
[5]  
BREEDIS C, 1954, AM J PATHOL, V30, P969
[6]   TRANSARTERIAL EMBOLIZATION FOR HEPATOCELLULAR-CARCINOMA - ANTIBIOTIC-PROPHYLAXIS AND CLINICAL MEANING OF POSTEMBOLIZATION FEVER [J].
CASTELLS, A ;
BRUIX, J ;
AYUSO, C ;
BRU, C ;
MONTANYA, X ;
BOIX, L ;
RODES, J .
JOURNAL OF HEPATOLOGY, 1995, 22 (04) :410-415
[7]   Hepatic tumors: Predisposing factors for complications of transcatheter oily chemoembolization [J].
Chung, JW ;
Park, JH ;
Han, JK ;
Choi, BI ;
Han, MC ;
Lee, HS ;
Kim, CY .
RADIOLOGY, 1996, 198 (01) :33-40
[8]   REGIONAL ANESTHESIA FOR HEPATIC ARTERIAL EMBOLIZATION [J].
COLDWELL, DM ;
LOPER, KA .
RADIOLOGY, 1989, 172 (03) :1039-1040
[9]   A call for standardizing the clinical rating of pain intensity using a 0 to 10 rating scale [J].
Dalton, JA ;
McNaull, F .
CANCER NURSING, 1998, 21 (01) :46-49
[10]   Unresectable hepatocellular carcinoma in cirrhosis - Survival, prognostic factors, and unexpected side effects after transcatheter arterial chemoembolization [J].
Farinati, F ;
DeMaria, N ;
Marafin, C ;
Herszenyi, L ;
DelPrato, S ;
Rinaldi, M ;
Perini, L ;
Cardin, R ;
Naccarato, R .
DIGESTIVE DISEASES AND SCIENCES, 1996, 41 (12) :2332-2339